Indeed, LC3B is thought to reside in the cell nucleus in an inactive acetylated form, which serves as a reservoir to be mobilised upon autophagy stimulation [23]; a different LC3 fraction associated with nuclear insulin receptor substrate 1 (IRS-1) has been suggested to attenuate autophagy in certain tumour cells [24]. The gene discussed is MAP1LC3B; the disease is neoplasm.